Learn More
The reduction of viral load is frequently used as a primary endpoint in HIV clinical trials. Non-linear mixed-effects models are thus proposed to model this decrease of the viral load after initiation of treatment and to evaluate the intra-and inter-patient variability. However, left censoring due to quantification limits in the viral load measurement is an(More)
OBJECTIVE Most patients with atrial fibrillation (AF) have risk factors and coexisting conditions that increase their mortality risk. We performed a cause-of-death analysis to identify predictors of mortality in hospitalised patients with AF in France. METHODS AND RESULTS In this retrospective, population-based cross-sectional study, the Programme de(More)
Artemisinin-based combination therapies (ACT) are widely used in African countries, including Cameroon. Between 2005 and 2007, five randomized studies comparing different treatment arms among artesunate-amodiaquine and other ACT were conducted in Cameroonian children aged two to 60 months who had uncomplicated Plasmodium falciparum malaria. In these(More)
  • 1